Core Insights - Rising Dragon Acquisition Corp. (RDAC.US) is a SPAC focused on finding and completing a merger with a private company by February 14, 2026 [1] Recent Events - The primary event in the SPAC lifecycle is identifying and announcing a merger target, which must occur within 18-24 months of the SPAC's inception. Any rumors or announcements regarding potential merger targets can significantly impact the stock price [2] - After announcing a merger target, the company must undergo shareholder voting and other procedures to finalize the transaction, transforming into a publicly listed company with actual business operations [2] - SPACs face pressure to complete a merger within the designated timeframe, as failure to do so may lead to liquidation and the return of funds (including interest) to shareholders. As the deadline approaches, market attention on the company's progress intensifies [2] Stock Performance - From December 31, 2025, to January 2026, the stock price of RDAC.US experienced significant volatility, with trading volume fluctuating. These movements are typically linked to market expectations regarding the SPAC's merger progress [3] - Recent financial reports indicate that the company has reported zero revenue, reflecting its status as a blank check company [3] Timeline Information - Currently, there is no specific timeline disclosed regarding the key events related to RDAC.US [4]

Core Viewpoint - The article discusses the rapid advancements and investments in nuclear fusion technology, highlighting the upcoming IPOs of companies like General Fusion and TAE Technologies, which are set to revolutionize the energy sector by providing nearly limitless energy potential [2][3]. Group 1: Company Developments - TAE Technologies, supported by Alphabet, has signed a merger agreement with Trump's media company, valuing the deal at over $6 billion [2]. - General Fusion has announced a merger with Spring Valley Acquisition Corp. III, with an estimated valuation of around $1 billion, aiming for a NASDAQ listing by mid-2026 [2]. - General Fusion's LM26, the first commercial-scale MTF demonstration device, has been completed and aims to achieve significant fusion technology milestones [7][8]. Group 2: Investment Trends - Global investment in nuclear fusion has surged from $1.9 billion in 2021 to $9.7 billion over the past five years, with the number of related companies increasing by 143% [3]. - In China, a startup named Xinghuan Fusion raised 1 billion yuan in a record financing round for private nuclear fusion companies [3]. Group 3: Market Dynamics - The nuclear fusion sector is experiencing a surge in interest, reminiscent of the semiconductor boom in 2015-2016, but there are concerns about the sustainability of this interest given the long-term nature of technological development [4]. - The article emphasizes the need for caution in the industry to avoid creating a bubble, as the technology's commercial viability is still uncertain [17]. Group 4: Technological Insights - The Tokamak is currently the most developed and largest investment route for controlled nuclear fusion, but it requires high investment and has a long commercialization timeline [6]. - General Fusion's MTF technology offers a potentially less complex and lower-cost alternative to Tokamak, utilizing mechanical pistons for plasma compression [7]. Group 5: Strategic Importance - Nuclear fusion is viewed as a strategic energy industry by major economies, with over 160 fusion devices in various stages of development globally [15]. - The article notes that top tech investors are increasingly backing fusion companies, indicating a strong belief in the technology's future [16].

Summary of Key Points Core Viewpoint - Six new stocks entered the US capital market on January 29, 2026, raising approximately $1.783 billion, with three additional companies set to list that evening, all of which are SPACs [1]. Group 1: Newly Listed Stocks - **York Space System (YSS)**: - Opened at $38 per share, up 11.76% from the offering price, but closed at $33.61, down 1.15%, with a total market capitalization of $4.201 billion [2]. - Issued 18.5 million shares at $34 each, raising $629 million. The company provides end-to-end critical solutions for space missions in the aerospace and defense sectors, reporting $281 million in revenue and a net loss of $56.04 million for the first nine months of 2025 [4]. - **Ethos Technologies (LIFE)**: - Opened at $19 per share, unchanged from the offering price, and closed at $16.85, down 11.32%, with a total market capitalization of $1.061 billion [5]. - Issued 10.53 million shares at $19 each, raising $200 million. The company operates a technology platform connecting consumers, agents, and insurance companies, reporting $277 million in revenue and a net profit of $46.59 million for the first nine months of 2025 [7]. - **Picpay (PICS)**: - Opened at $19.5 per share, a slight increase of 2.63%, and closed at $19, with a total market capitalization of $2.462 billion [7]. - Issued 22.86 million shares at $19 each, raising $434 million. The company serves the Brazilian market across various sectors, reporting $1.122 billion in revenue and a net profit of $59 million for the first nine months of 2025 [10]. Group 2: SPACs - Three SPACs listed: - **Xsolla SPAC 1 (XSLLU)** raised $200 million, targeting the video game industry and related sectors [10]. - **United Acquisition I (UACU)** raised $100 million, with no specific acquisition target yet identified, focusing on companies with strong management and competitive advantages [10]. - **K2 Capital Acquisition (KTWOU)** raised $120 million, concentrating on humanoid robotics, physical AI, and advanced energy sectors, particularly small modular nuclear reactors [10].

Group 1 - In 2025, 145 SPACs listed on the US stock market, accounting for 39.08% of the total new listings that year, indicating a strong momentum that may continue into this year [1] - Recently, two new stocks, BITGO HOLDINGS (BTGO) and Aldabra 4 Liquidity Opportunity Vehicle (ALOVU), were listed on the US stock market, with three additional SPACs, Spring Valley Acquisition IV (SVIVU) and Starlink AI Acquisition (OTAIU), submitting listing applications [1] - Aldabra 4 Liquidity Opportunity Vehicle, a special purpose acquisition company (SPAC), was initiated by Chairman Nathan Leight and aims to target companies valued between $500 million and $2 billion without limiting the industry or region [4] Group 2 - On January 22, Aldabra 4 Liquidity Opportunity Vehicle listed on NASDAQ at a price of $10 per share, issuing 26.1 million shares and raising $261 million [2] - Spring Valley Acquisition IV and Starlink AI Acquisition submitted their prospectuses to the SEC, seeking to raise $200 million and $60 million, respectively [5] - Spring Valley Acquisition IV focuses on energy, targeting the "power infrastructure" and "decarbonization" ecosystems, while Starlink AI Acquisition aims at blockchain, cryptocurrency, artificial intelligence, and fintech/energy tech sectors [6] Group 3 - Five SPACs are set to list tonight, including Legato Merger IV (LEGOU), Praetorian Acquisition (PTORU), Xsolla SPAC 1 (XSLLU), Helix Acquisition Corp. III (HLXC), and Archimedes Tech SPAC Partners III (ARCIU), raising funds of $200 million, $220 million, $250 million, $125 million, and $200 million, respectively [6] - Legato Merger IV, initiated by Director Gregory Monahan, plans to target the industrial and AI sectors [7] - Praetorian Acquisition, led by Director Justin Di Rezze, focuses on AI and automation, while Xsolla SPAC 1, chaired by Aleksandr Agapitov, emphasizes video games, fintech, ad tech, and telecommunications [7]

Core Viewpoint - Butterfly Network presented at the JPMorgan Conference, highlighting its significance in the healthcare sector and addressing recent developments regarding warrants issued to shareholders [2][3]. Company Developments - The company issued warrants to select shareholders at a price of $11.50, which are now expiring, leading to some confusion among investors [3]. - The expiration of these warrants means that there will be no dilution of 20 million shares for existing and new shareholders, which is viewed positively by the company [4].

Core Insights - The U.S. IPO market saw significant activity with two notable IPOs, Medline and Andersen Group, experiencing substantial stock price increases ahead of the Christmas holiday [1][2]. Group 1: IPO Highlights - Medline (MDLN) priced its IPO above the midpoint, raising $6.3 billion with a market capitalization of $38.7 billion. The company distributes and manufactures approximately 335,000 medical products and reported a 44% increase in stock price last week [1][3]. - Andersen Group (ANDG) priced its IPO at the midpoint, raising $176 million with a market capitalization of $1.9 billion. The firm provides tax, valuation, and financial consulting services to over 11,900 clients, with a stock price increase of 53% last week [1][3]. Group 2: SPAC Activity - Seven SPACs completed their pricing last week, with Churchill Capital XI (CCXIU) raising $360 million, Crane Harbor Acquisition II (CRANU) raising $300 million, and several others each raising $200 million targeting various sectors including technology, media, and energy [2][3]. - Notable SPACs include Iron Horse Acquisition (IRHOU) and American Drive Acquisition (ADACU), both raising $200 million, focusing on media and defense sectors respectively [2][3]. Group 3: Upcoming Filings - A total of ten companies submitted IPO applications, with ARKO Petroleum (APC) leading with a target of $100 million. Other notable applicants include Aktis Oncology (AKTS) and MiniMed Group (MMED), each also seeking $100 million [3][4]. - Eight SPACs also filed initial applications, with M Evo Global Acquisition (MEVOU) targeting $225 million for critical minerals and Cambridge Acquisition (CAQU) targeting $200 million for technology [4][5]. Group 4: Market Outlook - The IPO market is expected to remain quiet during the Christmas holiday period, with no major IPO plans announced for the upcoming week, although smaller issuers may join the schedule [7].

Group 1: Andersen Group IPO - Andersen Group priced its IPO at $16 per share, at the high end of the previously set range of $14 to $16 [1] - The company raised $176 million by issuing 11 million shares, resulting in a fully diluted market capitalization of $1.9 billion [1] - Andersen Group, founded in 2002, provides independent tax, valuation, and financial consulting services to over 11,900 clients across the U.S. [2] - The company is a member of Andersen Global, which consists of over 300 member firms and partners [2] - Andersen Group is listed on the New York Stock Exchange under the ticker symbol ANDG, with several investment banks acting as joint bookrunners for the transaction [2] Group 2: Iron Horse Acquisition II IPO - Iron Horse Acquisition II, a SPAC focused on media and entertainment, completed its IPO by raising $200 million through the issuance of 20 million units priced at $10 each [3] - The initial plan was to issue 25 million units, but the final structure included 1 share of common stock and 1 warrant per unit [3][4] - The company is led by CEO Jose Bengochea, who is also the founder of Bengochea Capital, and aims to focus on sectors like music, animation, and artificial intelligence [3] Group 3: Churchill Capital XI IPO - Churchill Capital XI, a SPAC founded by Michael Klein, raised $360 million by issuing 36 million units at $10 each, exceeding its initial expectations by 6 million units [6] - Each unit consists of 1 share of common stock and a warrant with an exercise price of $11.50 [6] - The company is focused on acquiring businesses that generate stable free cash flow and have strong management teams [7] - Churchill Capital XI is listed on NASDAQ under the ticker symbol CCXIU, with Citigroup serving as the sole bookrunner for the transaction [8] Group 4: Spectre Acquisition IPO - Spectre Acquisition, led by Chinese executives, filed for an IPO to raise up to $60 million by issuing 6 million units at $10 each [9] - Each unit includes 1 share of common stock and a full warrant with an exercise price of $11.50 [9] - The SPAC plans to target companies outside mainland China that possess key technologies and strong competitive positions [9]

Group 1: Medline's IPO Details - Medline has priced its IPO at $29 per share, above the midpoint of the initial pricing range, raising $6.3 billion by issuing 216 million shares [3] - The company initially planned to issue 170 million shares, with the proceeds expected to be used for share buybacks from existing shareholders [3] - The fully diluted market capitalization of Medline is estimated at $38.7 billion, which is 4% higher than previous expectations [3] Group 2: Medline's Business Operations - Medline is a major distributor and manufacturer of medical surgical products, offering approximately 335,000 products across two main business segments: Medline brand products and supply chain solutions [4] - About one-third of Medline's branded products are produced in its 33 global manufacturing facilities, while the rest are sourced from over 500 suppliers [4] - The company operates a distribution network with 69 distribution centers and over 2,000 trucks, enabling it to serve approximately 95% of U.S. customers within a day [4] Group 3: Underwriters and Coordinators - Goldman Sachs, Morgan Stanley, Bank of America Securities, and JPMorgan Chase are serving as global coordinators and lead underwriters for the IPO [5] - A range of other banks, including Barclays, Citigroup, and Deutsche Bank Securities, are acting as book managers for the offering [5] Group 4: One Universe Acquisition SPAC - One Universe Acquisition, a SPAC led by Chinese executives, has filed for an IPO to raise up to $60 million by offering 6 million shares at $10 each [6] - The SPAC aims to acquire companies with strong management teams, mature products, and reliable revenue sources [7] - One Universe Acquisition plans to list on NASDAQ under the ticker symbol ONEU and was established in 2025 [7]

Core Viewpoint - The article discusses the strategic choices Chinese companies face when considering listing in the U.S., highlighting the traditional IPO and the emerging SPAC as two main pathways for international expansion and growth [1]. Group 1: Traditional IPO - A Stable Choice - IPOs are a classic model that has been tested over time, offering deep value discovery and structural stability [2]. - Key advantages include transparent valuation based on detailed financial disclosures and market roadshows, which reflect the company's fundamentals and growth potential [3]. - The IPO process involves rigorous due diligence and regulatory scrutiny, leading to a stable equity structure that attracts long-term institutional investors [3]. - Successfully listing on a major exchange after passing SEC scrutiny enhances the company's international brand reputation [3]. Group 2: Potential Challenges of IPO - The IPO process can be lengthy, typically taking 6-12 months or longer, with stringent SEC reviews of financial, legal, and business information [4]. - High intermediary costs and market sentiment can create uncertainty regarding the success of the issuance and pricing, with risks of delays or lower-than-expected valuations during market turbulence [4]. Group 3: SPAC - An Efficient Pathway - SPACs provide a more efficient listing option for certain types of companies, allowing for quicker access to public markets [5]. - The process is faster, typically completed within 3-6 months, avoiding the complexities of traditional IPOs [6]. - Valuation is flexible and can be negotiated directly with the SPAC sponsor, making it suitable for high-growth companies with innovative business models that may not yet be profitable [6]. - SPACs offer a viable listing route for companies that do not fully meet traditional IPO financial criteria but possess disruptive technologies [6]. Group 4: Potential Risks of SPAC - Merging with a SPAC requires shareholder approval, and doubts about the target company's quality can lead to significant redemptions, risking transaction failure or reduced financing [7]. - Initial stock price volatility may be high post-listing, and companies must bear some operational and incentive costs associated with the SPAC [7]. - Despite a faster process, companies still undergo rigorous business, financial, and legal due diligence to meet regulatory requirements [7]. Group 5: Choosing Between IPO and SPAC - The choice between IPO and SPAC is not a simple good or bad evaluation but should align with the company's strategic situation [10]. - Companies suited for IPOs typically have mature business models, stable growth records, and robust financial systems, seeking solid valuations and stable investor structures without urgency for short-term listing [10]. - Companies that may prefer SPACs are often in high-growth sectors (e.g., renewable energy, biotech) and may not be profitable yet but have clear future growth trajectories, requiring quick capital access to seize market opportunities [10].

Group 1 - Colombier Acquisition Corp. III, a SPAC supported by Omeed Malik, filed for an IPO with the SEC, aiming to raise $260 million by offering 26 million shares at $10 each [1] - The company plans to list its units on the New York Stock Exchange under the ticker "CLBR U," with Roth Capital acting as the underwriter for the offering [1] - Units in the SPAC context typically consist of one common stock and a fraction of a warrant, allowing investors to trade them separately after the initial purchase [1] Group 2 - 1789 Capital, co-founded by Omeed Malik and Chris Buskirk in 2022, aims to fund the next chapter of American exceptionalism, with Malik being a significant donor to Donald Trump's campaign [2] - Chamath Palihapitiya, a notable figure on Wall Street known for leading high-profile SPAC transactions, is also a board member of Colombier Acquisition Corp. III [2] - The IPO represents a recent investment move by the Trump family, which has previously engaged in various ventures, including a meme coin project and a cryptocurrency company [2]